E
Elsebeth Lynge
Researcher at University of Copenhagen
Publications - 484
Citations - 19048
Elsebeth Lynge is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Population & Breast cancer. The author has an hindex of 59, co-authored 461 publications receiving 17055 citations. Previous affiliations of Elsebeth Lynge include Statens Serum Institut & Karolinska Institutet.
Papers
More filters
Journal Article
Equity and improvement in outcome of breast cancer in Denmark
TL;DR: It is reasonable to assume that the national programme introduced in 1977 by the Danish Breast Cancer Cooperative Group (DBCG) has played an important role and not only brought about therapeutic improvements in breast cancer treatment in Denmark, but also ensured equity in the outcome on a national scale.
Journal ArticleDOI
Residential traffic noise and mammographic breast density in the Diet, Cancer, and Health cohort.
Nina Roswall,Zorana Jovanovic Andersen,My von Euler-Chelpin,Ilse Vejborg,Elsebeth Lynge,Steen Solvang Jensen,Ole Raaschou-Nielsen,Anne Tjønneland,Mette Sørensen +8 more
TL;DR: A cohort of middle-aged Danish women with reproductive and lifestyle information available from the Diet, Cancer, and Health cohort found no association between residential road and railway noise exposure 5 years before mammogram, and having a mixed/dense versus a fatty mammogram.
Journal ArticleDOI
Impact of chronic diseases on effect of breast cancer screening
Anna-Belle Beau,George Napolitano,Marianne Ewertz,Ilse Vejborg,Walter Schwartz,Per Kragh Andersen,Elsebeth Lynge +6 more
TL;DR: The impact of health status on the effect of breast cancer screening is investigated and subgroups of women may benefit differently.
Journal ArticleDOI
Hospital Volume of Antireflux Surgery in Relation to Endoscopic and Surgical Re-interventions.
Sheraz R. Markar,Sheraz R. Markar,Giola Santoni,John Maret-Ouda,Miia Artama,Martti Färkkilä,Elsebeth Lynge,Eero Pukkala,Eivind Ness-Jensen,Eivind Ness-Jensen,My von Euler-Chelpin,Jesper Lagergren,Jesper Lagergren +12 more
TL;DR: Higher hospital volume of primary antireflux surgery may not decrease risk of endoscopic or surgical re-intervention, suggesting that centralization will not decrease rates of postoperative complications or recurrence of gastro-esophageal reflux disease.